share_log

Form 144 | 奥洛兹美医疗(HALO.US)高管拟出售1万股股份,价值约52.04万美元

Form 144 | Halozyme Therapeutics(HALO.US) Officer Proposes to Sell 520.4K in Common Stocks

Moomoo News ·  Jun 28 16:53

SEC FILLINGS DISCLOSED/ Jun 28, $Halozyme Therapeutics (HALO.US)$ Officer NICOLE LABROSSE intends to sell 10,000 shares of its common stock on Jun 28, with a total market value of approximately $520.4K.

NICOLE LABROSSE has reduced shareholding in $Halozyme Therapeutics (HALO.US)$ by 20,000 shares since Jun 26, 2024, with a total value of approximately $1.04 million.

1719608039066599168.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment